Home › Funds › ARCH Venture Management, LLC › RAPP

ARCH Venture Management, LLC position in RAPP

RAPPORT THERAPEUTICS INC · Health Care

ARCH Venture Management, LLC reported holding 3,728,738 shares of RAPP (RAPPORT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$155.4M, representing 14.12% of its reported portfolio and ranking #3 among its reported holdings. ARCH Venture Management, LLC has disclosed RAPP holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)3.73M sh
Reported value held$155.38M
Portfolio Weight14.12%
First reportedQ2 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ARCH Venture Management, LLC's RAPP position evolved

ARCH Venture Management, LLC first disclosed a stake in RAPP in Q2 2024 at 3,728,738 shares (US$86.7M). The position peaked in Q2 2026 at 3,728,738 shares, worth US$155.4M. Across 9 filings, ARCH Venture Management, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 3,728,738 shares valued at US$155.4M.

Quarter by quarter

QuarterSharesValueChange
Q2 2024 3.73M $86.73M New
Q3 2024 3.73M $76.36M Hold
Q4 2024 3.73M $66.15M Hold
Q1 2025 3.73M $37.55M Hold
Q2 2025 3.73M $42.43M Hold
Q3 2025 3.73M $110.74M Hold
Q4 2025 3.73M $113.13M Hold
Q1 2026 3.73M $116.67M Hold
Q2 2026 3.73M $155.38M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RAPP and 13F data

RAPP (RAPPORT THERAPEUTICS INC) is a Health Care company. 66 other funds we track also report a position in RAPP — the largest reported positions include TRV GP V, LLC (US$261.7M), Cormorant Asset Management, LP (US$110.7M), Sofinnova Investments, Inc. (US$79.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RAPP

All RAPP fund holders →

FAQ

How long has ARCH Venture Management, LLC held RAPP?

ARCH Venture Management, LLC has disclosed RAPP holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is ARCH Venture Management, LLC's current position in RAPP?

As of Q2 2026, ARCH Venture Management, LLC holds 3.73M shares of RAPP (RAPPORT THERAPEUTICS INC), valued at $155.38M, representing 14.12% of its reported portfolio and ranking #3.

Has ARCH Venture Management, LLC been buying or selling RAPP?

In the latest 13F filing (Q2 2026), ARCH Venture Management, LLC held unchanged its position in RAPP. The position peaked in Q2 2026 at 3.73M shares.

Which other funds hold RAPP?

Other major institutional holders of RAPP include TRV GP V, LLC, Cormorant Asset Management, LP, Sofinnova Investments, Inc., among 66 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.